MEIHUA INTL MEDICAL- CLASS A (MHUA) Fundamental Analysis & Valuation

NASDAQ:MHUA • KYG5966G1082

Current stock price

7.61 USD
-6.41 (-45.72%)
At close:
6.11 USD
-1.5 (-19.71%)
After Hours:

This MHUA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MHUA Profitability Analysis

1.1 Basic Checks

  • In the past year MHUA was profitable.
  • In the past year MHUA had a positive cash flow from operations.
  • Each year in the past 5 years MHUA has been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • With an excellent Return On Assets value of 7.34%, MHUA belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 8.48%, MHUA belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.79%, MHUA belongs to the top of the industry, outperforming 83.96% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for MHUA is below the industry average of 9.31%.
  • The last Return On Invested Capital (7.79%) for MHUA is above the 3 year average (6.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROIC 7.79%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 10.37%, MHUA belongs to the best of the industry, outperforming 84.49% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MHUA has declined.
  • With an excellent Operating Margin value of 13.01%, MHUA belongs to the best of the industry, outperforming 80.75% of the companies in the same industry.
  • MHUA's Operating Margin has declined in the last couple of years.
  • The Gross Margin of MHUA (34.04%) is worse than 74.87% of its industry peers.
  • In the last couple of years the Gross Margin of MHUA has declined.
Industry RankSector Rank
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. MHUA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MHUA is creating some value.
  • The number of shares outstanding for MHUA has been increased compared to 1 year ago.
  • MHUA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MHUA has about the same debt to assets ratio.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.79 indicates that MHUA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.79, MHUA is doing good in the industry, outperforming 69.52% of the companies in the same industry.
  • MHUA has a debt to FCF ratio of 3.19. This is a good value and a sign of high solvency as MHUA would need 3.19 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.19, MHUA belongs to the top of the industry, outperforming 82.89% of the companies in the same industry.
  • MHUA has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
  • MHUA's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. MHUA outperforms 66.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Altman-Z 2.79
ROIC/WACC1.68
WACC4.63%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • MHUA has a Current Ratio of 5.71. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
  • MHUA has a better Current ratio (5.71) than 81.28% of its industry peers.
  • A Quick Ratio of 5.66 indicates that MHUA has no problem at all paying its short term obligations.
  • MHUA has a better Quick ratio (5.66) than 83.96% of its industry peers.
Industry RankSector Rank
Current Ratio 5.71
Quick Ratio 5.66
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. MHUA Growth Analysis

3.1 Past

  • The earnings per share for MHUA have decreased strongly by -22.59% in the last year.
  • The earnings per share for MHUA have been decreasing by -13.75% on average. This is quite bad
  • The Revenue has decreased by -5.30% in the past year.
  • Measured over the past years, MHUA shows a small growth in Revenue. The Revenue has been growing by 4.01% on average per year.
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

4. MHUA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.53 indicates a correct valuation of MHUA.
  • 87.17% of the companies in the same industry are more expensive than MHUA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of MHUA to the average of the S&P500 Index (24.88), we can say MHUA is valued slightly cheaper.
Industry RankSector Rank
PE 15.53
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MHUA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.19
EV/EBITDA -0.62
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. MHUA Dividend Analysis

5.1 Amount

  • No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield 0%

MHUA Fundamentals: All Metrics, Ratios and Statistics

MEIHUA INTL MEDICAL- CLASS A

NASDAQ:MHUA (12/8/2025, 8:26:08 PM)

After market: 6.11 -1.5 (-19.71%)

7.61

-6.41 (-45.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29
Earnings (Next)N/A
Inst Owners0.23%
Inst Owner Change-100%
Ins Owners28.5%
Ins Owner ChangeN/A
Market Cap4.26M
Revenue(TTM)134.89M
Net Income(TTM)13.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.53
Fwd PE N/A
P/S 0.03
P/FCF 1.19
P/OCF 1.15
P/B 0.03
P/tB 0.03
EV/EBITDA -0.62
EPS(TTM)0.49
EY6.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.4
FCFY84.13%
OCF(TTM)6.64
OCFY87.26%
SpS240.88
BVpS294.54
TBVpS293.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number56.99
Profitability
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROCE 10.64%
ROIC 7.79%
ROICexc 8.54%
ROICexgc 8.57%
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
FCFM 2.66%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexgc growth 3Y-27.75%
ROICexgc growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Debt/EBITDA 0.63
Cap/Depr 24.05%
Cap/Sales 0.1%
Interest Coverage 69.48
Cash Conversion 20.54%
Profit Quality 25.63%
Current Ratio 5.71
Quick Ratio 5.66
Altman-Z 2.79
F-Score5
WACC4.63%
ROIC/WACC1.68
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.66%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%

MEIHUA INTL MEDICAL- CLASS A / MHUA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MEIHUA INTL MEDICAL- CLASS A?

ChartMill assigns a fundamental rating of 5 / 10 to MHUA.


What is the valuation status of MEIHUA INTL MEDICAL- CLASS A (MHUA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MEIHUA INTL MEDICAL- CLASS A (MHUA). This can be considered as Fairly Valued.


What is the profitability of MHUA stock?

MEIHUA INTL MEDICAL- CLASS A (MHUA) has a profitability rating of 6 / 10.


What is the financial health of MEIHUA INTL MEDICAL- CLASS A (MHUA) stock?

The financial health rating of MEIHUA INTL MEDICAL- CLASS A (MHUA) is 7 / 10.